FLPIM
RDHL

F.L. Putnam Investment Management’s Redhill Biopharma RDHL Stock Holding History

F.L. Putnam Investment Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$34 – 701
2024
Q2 		$34 Buy
+4
New +$44 ﹤0.01% 727

Other funds holding RDHL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

F.L. Putnam Investment Management's RDHL Position: Q3 2024 in Review

F.L. Putnam Investment Management sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 4 shares — an estimated $34 sold.

F.L. Putnam Investment Management first reported a position in RDHL in Q2 2024 and held it in 1 quarter. The position peaked at $34 in Q2 2024. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

  • F.L. Putnam Investment Management reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
  • F.L. Putnam Investment Management sold 4 Redhill Biopharma shares in Q3 2024, an estimated $34.
  • F.L. Putnam Investment Management first reported a position in Redhill Biopharma in Q2 2024 and held it in 1 quarter.
  • F.L. Putnam Investment Management's Redhill Biopharma position peaked at $34 in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on F.L. Putnam Investment Management's 13F filing for Q3 2024, filed 8 Nov 2024.